CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b Multi-cohort Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04806035
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:20.197313+00:00
Published At: 2024-07-31T00:00:00+00:00
Record Updated At: 2024-07-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["CLL", "SLL", "Richter\u0027s Transformation", "Indolent Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma", "Aggressive Lymphoma", "DLBCL", "Mediastinal Large B-cell Lymphoma", "MCL"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-31"
protocolSection.identificationModule.nctId: "NCT04806035"
protocolSection.identificationModule.officialTitle: "A Phase 1b Multi-cohort Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.